Authors

• Hidenori Takahashi (ORCID: https://orcid.org/0000-0001-5331-4730)
• Tina Maio‐Twofoot
• Hidetaka Matsumoto (ORCID: https://orcid.org/0000-0003-2311-0280)
• Hélène Karcher (ORCID: https://orcid.org/0000-0003-0798-4084)
• Masayuki Ohnaka (ORCID: https://orcid.org/0000-0001-9187-8887)
• Kazuaki Kadonosono (ORCID: https://orcid.org/0000-0003-3568-9111)
• Yoichi Sakurada (ORCID: https://orcid.org/0000-0002-2894-0454)
• Yuki Murata (ORCID: https://orcid.org/0000-0002-3750-1410)
• Atsushi Hayashi (ORCID: https://orcid.org/0000-0003-2885-1141)
• Hitoshi Ohno (ORCID: https://orcid.org/0000-0002-4348-4450)
• Ryusaburo Mori (ORCID: https://orcid.org/0000-0002-1124-6861)
• Ippei Nagamori

Institutions

• Nihon University (JP)
• Kansai Medical University (JP)
• Novartis (Switzerland) (CH)
• Jichi Medical University (JP)
• Gunma University (JP)
• Novartis (Japan) (JP)
• Minamiaoyama Eye Clinic (JP)
• University of Toyama (JP)
• University of Yamanashi (JP)
• Yokohama City University (JP)

Publication Details

Journal

Ophthalmology and Therapy

Published

2025-05-27

DOI

https://doi.org/10.1007/s40123-025-01159-2

Citations

2

Primary Topic

Retinal Diseases and Treatments

Type

article

Field-Weighted Citation Impact

3.41

Funders

• Novartis